{"id":629524,"date":"2024-08-20T13:50:54","date_gmt":"2024-08-20T17:50:54","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=629524"},"modified":"2026-09-23T14:41:19","modified_gmt":"2026-09-23T18:41:19","slug":"fiasp-flextouch-without-insurance","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/fiasp-flextouch-without-insurance\/","title":{"rendered":"How much is Fiasp without insurance?"},"content":{"rendered":"

Fiasp<\/a> is a brand-name fast-acting insulin product<\/a> containing insulin aspart that helps control mealtime blood sugar levels in people with diabetes mellitus. In addition to being sold in vials, Fiasp is available as a prefilled insulin pen (Fiasp FlexTouch<\/a>), as cartridges for compatible Novo Nordisk insulin pens (Fiasp PenFill<\/a>), or as cartridges for use in a compatible insulin pump (Fiasp PumpCart<\/a>). Without insurance, the cost of five Fiasp FlexTouch pens can exceed $140. Fiasp vials and cartridges may cost less, and people without insurance may be able to save on Fiasp products with discount cards, savings offers, and other strategies.<\/p>\n

RELATED: <\/b>Diabetes coupons & discount diabetic supplies<\/b><\/a><\/p>\n

Is there a generic for Fiasp?<\/h2>\n

Currently, no generic version of Fiasp products is available. Fiasp, which is manufactured by Novo Nordisk, contains insulin aspart and niacinamide (vitamin B3), which helps increase the speed of insulin absorption<\/a> after injection. A key Fiasp formulation patent is expected to expire in 2030<\/a>, after which a generic version may be made available.<\/p>\n

Novolog<\/a> is another rapid-acting insulin that, like Fiasp, contains insulin aspart. However, the two products have different formulations. NovoLog is not a generic or biosimilar version of Fiasp FlexTouch<\/a>.<\/p>\n

RELATED: <\/b>Fiasp vs. Novolog: differences and similarities explained<\/b><\/a><\/p>\n

Is Fiasp covered by insurance?<\/h2>\n

Fiasp FlexTouch and other Fiasp products may be covered by private health insurance and Medicare, but coverage varies by plan. Check your plan\u2019s formulary or contact your insurer or pharmacist to confirm your Fiasp insurance coverage and out-of-pocket costs.<\/p>\n

Medicare typically covers Fiasp FlexTouch under Medicare Part D<\/a> or Medicare Advantage plans, but, again, some plans don\u2019t. Coverage details, such as copay amounts, can differ greatly.<\/p>\n

Some insurance plans may require prior authorization<\/a> before covering Fiasp. This means your healthcare provider may need to submit information showing that the medication is medically necessary. Other out-of-pocket costs and coverage requirements can vary by plan.<\/p>\n

How much does Fiasp cost without insurance?<\/h2>\n

The Fiasp cost without insurance depends on the format prescribed. As of the time of publication, the Fiasp FlexTouch cost without insurance is about $140 for five pens. Each pen contains 3 milliliters (mL) of insulin with a concentration of 100 units\/mL, totaling 300 units per pen. In a box of five pens, there are 1,500 units of insulin.<\/p>\n

To understand the costs better, here’s a breakdown:<\/p>\n